Search Results - lou+ann+brown

1 Results Sort By:
Combination of Tetrahydrobiopterin and Arginine/ ± Arginase Inhibitors for the Treatment of COVID-19
­ Application A novel drug combination to address acute arginine/BH4 dysregulation that develops with COVID-19 and MIS-C infection. Key Benefits Potential to improve outcomes of those infected with COVID-19 with few side effects. Repurposing opportunity with the combination of two approved drugs (tetrahydrobiopterin and arginine). Addresses...
Published: 3/11/2026   |   Updated: 3/16/2022   |   Inventor(s): Claudia Morris, Lou Ann Brown
Keywords(s): COVID19, Microbiology and Infectious Disease Treatments, Repurposed Drug
Category(s): TechPub Algolia > Therapeutics